| 000 | 01082 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513061342.0 | ||
| 264 | 0 | _c19930819 | |
| 008 | 199308s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.306.6892.1610-c _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSears, M R | |
| 245 | 0 | 0 |
_aBronchodilator treatment in asthma. Increase in deaths during salmeterol treatment unexplained. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cJun 1993 |
||
| 300 |
_a1610-1 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Agonists _xtherapeutic use |
| 650 | 0 | 4 |
_aAlbuterol _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 |
_aBronchodilator Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aProduct Surveillance, Postmarketing |
| 650 | 0 | 4 | _aSalmeterol Xinafoate |
| 700 | 1 | _aTaylor, D R | |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 306 _gno. 6892 _gp. 1610-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.306.6892.1610-c _zAvailable from publisher's website |
| 999 |
_c8100439 _d8100439 |
||